This page follows insider dealings at AS One Corporation as filed with EDINET (Japan FSA), a company from the Health Care sector. In the past year (18 October 2025 to 18 October 2026), 16 filings came from 4 insiders.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
No insider has bought AS One Corporation shares on the open market in the past twelve months. The median gap between a trade and its publication by EDINET (Japan FSA) is 6 days. Until a filing is published, the market cannot know about the trade.
For context, the typical company on the same exchange (median of 3,427 companies) published 3 filings over the same period, against 16 filings here.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. These figures are compiled from regulatory filings published by EDINET (Japan FSA). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended March 2026 · cache
25 of 53 declarations
As One Corporation is a Japanese company specializing in health and pharmaceuticals. It operates on the XTKS market.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 6 filings published between 12 August and 8 October 2026: no open-market purchase or sale filed by an insider. 6 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 14 October 2026 (UTC)